Ken Griffin Olink Holding Ab (Publ) Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$21.87 - $25.59 $19,683 - $23,031	900 Added 2.69%	34,400 $876,000
Q1 2024 May 15, 2024	SELL	$21.81 - $25.14 $13,086 - $15,084	-600 Reduced 1.76%	33,500 $787,000
Q4 2023 Feb 14, 2024	BUY	$14.29 - $25.95 $125,751 - $228,360	8,800 Added 34.78%	34,100 $857,000
Q3 2023 Nov 14, 2023	BUY	$14.45 - $20.34 $105,485 - $148,482	7,300 Added 40.56%	25,300 $373,000
Q2 2023 Aug 14, 2023	SELL	$17.13 - $23.74 $59,955 - $83,090	-3,500 Reduced 16.28%	18,000 $337,000
Q1 2023 May 15, 2023	SELL	$19.34 - $24.11 $1.37 Million - $1.7 Million	-70,600 Reduced 76.66%	21,500 $484,000
Q4 2022 Feb 14, 2023	BUY	$12.64 - $25.52 $884,800 - $1.79 Million	70,000 Added 316.74%	92,100 $2.34 Million
Q3 2022 Nov 14, 2022	BUY	$12.14 - $18.42 $54,630 - $82,890	4,500 Added 25.57%	22,100 $268,000

799K

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.